These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 2623393)
1. [Presentation and therapeutic indication for blood derivatives]. Brévière D Soins Chir; 1989 Dec-1990 Jan; (106-107):30-40. PubMed ID: 2623393 [No Abstract] [Full Text] [Related]
2. [Current therapy with blood and blood derivatives]. Gelabert A; Puig L; Mazzara R Med Clin (Barc); 1983 Apr; 80(12):550-9. PubMed ID: 6345950 [No Abstract] [Full Text] [Related]
3. [The main characteristics of blood products in current use]. Lambert T Rev Prat; 1989 Sep; 39(20):1745-9. PubMed ID: 2814257 [TBL] [Abstract][Full Text] [Related]
4. [Recommendations from the 12th Scandinavian meeting on transfusion medicine]. Eklund J; Jørgensen J; Högman C; Jensson O; Kornstad L Nord Med; 1990; 105(4):119-20. PubMed ID: 2111542 [No Abstract] [Full Text] [Related]
5. [Paroxysmal nocturnal hemoglobinuria. III. Therapeutic measures]. Solovera Cano JJ; Frieyro Seguí JE; Ruiz Galiana J; Masa Vázquez C; Fraile de Abajo L; Posada M; Pérez Maestu R Rev Clin Esp; 1981 Jan; 160(1):65-8. PubMed ID: 7209054 [No Abstract] [Full Text] [Related]
6. [Therapeutic use of hemoderivatives]. Yurrebaso Eguilior N; Mota Villaplana FM; Montoro Ronsano JB Sangre (Barc); 1997 Oct; 42(5):423-7. PubMed ID: 9424747 [No Abstract] [Full Text] [Related]
7. [Indications for whole blood transfusion or erythrocyte concentrates and transfusion of washed erythrocytes with or without simultaneous heparin administration in paroxysmal nocturnal hemoglobinuria (HPN)]. Guasch J Sangre (Barc); 1969; 14(3):358-61. PubMed ID: 5406587 [No Abstract] [Full Text] [Related]
9. Management of paroxysmal cold haemoglobinuria: not only avoiding cold but also keeping warm. Win N; Roberts DJ Br J Haematol; 2008 Aug; 142(4):668. PubMed ID: 18573114 [No Abstract] [Full Text] [Related]
10. [Marchiafava-Micheli hemolytic anemia; results of treatment with ACTH, cortisone and transfusion of erythrocytes]. LEONARDI P; LOCATELLI C Acta Med Patav; 1955; 15(3):366-96. PubMed ID: 13394164 [No Abstract] [Full Text] [Related]
12. [Blood products and plasma derivatives]. Faber JC Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):45-53. PubMed ID: 3242960 [No Abstract] [Full Text] [Related]
13. [Plasmapheresis . (Technic. Results. Treatment of the syndrome of hyperviscosity in dysglobulinemias)]. Combrisson-le Bolloch A; Pechere JC; Andre R Transfusion (Paris); 1966; 9(2):139-55. PubMed ID: 5922441 [No Abstract] [Full Text] [Related]
14. A possible anti-D autosensitization in a D (Rh0) negative patient. Strada P; Rasore Quartino A; Mori PG; Soldà AM; Adami R; Haupt R; Reali G Haematologica; 1983; 68(5):656-63. PubMed ID: 6416943 [No Abstract] [Full Text] [Related]
15. [Rationalization of the use of blood and blood preparations]. Ninomiya K Rinsho Byori; 1991 Mar; Suppl 88():20-8. PubMed ID: 1856969 [No Abstract] [Full Text] [Related]
16. [Modern trends in nocturnal paroxysmal hemoglobinuria. Clinical and ultrastructural aspects of 2 cases]. Brunetti M; Castaldi C; D'Amore F; Rivosecchi L; Amici D Minerva Med; 1980 Jul; 71(29):2053-62. PubMed ID: 7402489 [No Abstract] [Full Text] [Related]
17. [Blood replacement and plasma expanders (I). Therapeutic use of blood and blood components]. Vlaho M; Gross R ZFA (Stuttgart); 1981 Apr; 57(12):931-6. PubMed ID: 7281927 [No Abstract] [Full Text] [Related]